By Nigel Somerville, the Deputy Sheriff of AIM | Wednesday 13 July 2016
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Tom Winnifrith described the deal under which AIM-listed E-Therapeutics (ETX) repurchased a company called Searchbolt (having spun it off some while back) as stinking like a pile of rotting kippers at the height of summer. In the event, two directors of E-Therapeutics ended up with (between them) almost 3.4 million shares in the company from the transaction. Now the CEO (who accounted for 3,350,228 of those shares – plus a cash sum to cover capital gains tax) has quit with immediate effect.
Filed under:
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Time left: 17:36:40